Trial Outcomes & Findings for Telemedicine Enhanced Asthma Management Through the Emergency Department (NCT NCT02752165)

NCT ID: NCT02752165

Last Updated: 2025-09-05

Results Overview

Number of days without symptoms in the prior 2 weeks

• Recruitment status: COMPLETED
• Study phase: NA
• Target enrollment: 384 participants
• Primary outcome timeframe: At the 3-month follow-up assessment
• Results posted on: 2025-09-05

Participant Flow

Recruitment occurred in two emergency departments in Rochester, NY in 2016-2021.

Participants were screened for inclusion/exclusion criteria (age, zip code, asthma severity, reason for emergency visit, foster care, etc.) at the time of the visit to the emergency room. Children were excluded if they did not meet enrollment criteria.

Participant milestones

Measure	TEAM-ED Intervention Group Facilitation of preventive asthma management through telemedicine assessment and follow-ups in addition to guideline-based provider prompting TEAM-ED: Facilitation of preventive asthma management through telemedicine assessment and follow-ups in addition to guideline-based provider prompting	Enhanced Usual Care Report of symptoms to primary care physician Enhanced Usual Care: Report of symptoms to primary care physician
Overall Study STARTED	191	193
Overall Study COMPLETED	146	144
Overall Study NOT COMPLETED	45	49

Reasons for withdrawal

Measure	TEAM-ED Intervention Group Facilitation of preventive asthma management through telemedicine assessment and follow-ups in addition to guideline-based provider prompting TEAM-ED: Facilitation of preventive asthma management through telemedicine assessment and follow-ups in addition to guideline-based provider prompting	Enhanced Usual Care Report of symptoms to primary care physician Enhanced Usual Care: Report of symptoms to primary care physician
Overall Study Withdrawal by Subject	6	6
Overall Study Protocol Violation	6	5
Overall Study Lost to Follow-up	33	38

Baseline Characteristics

Telemedicine Enhanced Asthma Management Through the Emergency Department

Baseline characteristics by cohort

Measure	TEAM-ED Intervention Group n=185 Participants Facilitation of preventive asthma management through telemedicine assessment and follow-ups in addition to guideline-based provider prompting TEAM-ED: Facilitation of preventive asthma management through telemedicine assessment and follow-ups in addition to guideline-based provider prompting	Enhanced Usual Care n=188 Participants Report of symptoms to primary care physician Enhanced Usual Care: Report of symptoms to primary care physician	Total n=373 Participants Total of all reporting groups
Age, Continuous	6.3 years STANDARD_DEVIATION 2.6 • n=5 Participants	6.5 years STANDARD_DEVIATION 1.8 • n=7 Participants	6.4 years STANDARD_DEVIATION 2.7 • n=5 Participants
Sex: Female, Male Female	74 Participants n=5 Participants	75 Participants n=7 Participants	149 Participants n=5 Participants
Sex: Female, Male Male	111 Participants n=5 Participants	113 Participants n=7 Participants	224 Participants n=5 Participants
Ethnicity (NIH/OMB) Hispanic or Latino	64 Participants n=5 Participants	57 Participants n=7 Participants	121 Participants n=5 Participants
Ethnicity (NIH/OMB) Not Hispanic or Latino	121 Participants n=5 Participants	131 Participants n=7 Participants	252 Participants n=5 Participants
Ethnicity (NIH/OMB) Unknown or Not Reported	0 Participants n=5 Participants	0 Participants n=7 Participants	0 Participants n=5 Participants
Race (NIH/OMB) American Indian or Alaska Native	1 Participants n=5 Participants	0 Participants n=7 Participants	1 Participants n=5 Participants
Race (NIH/OMB) Asian	3 Participants n=5 Participants	2 Participants n=7 Participants	5 Participants n=5 Participants
Race (NIH/OMB) Native Hawaiian or Other Pacific Islander	0 Participants n=5 Participants	0 Participants n=7 Participants	0 Participants n=5 Participants
Race (NIH/OMB) Black or African American	94 Participants n=5 Participants	106 Participants n=7 Participants	200 Participants n=5 Participants
Race (NIH/OMB) White	17 Participants n=5 Participants	15 Participants n=7 Participants	32 Participants n=5 Participants
Race (NIH/OMB) More than one race	30 Participants n=5 Participants	32 Participants n=7 Participants	62 Participants n=5 Participants
Race (NIH/OMB) Unknown or Not Reported	40 Participants n=5 Participants	33 Participants n=7 Participants	73 Participants n=5 Participants
Region of Enrollment United States	185 participants n=5 Participants	188 participants n=7 Participants	373 participants n=5 Participants
Mean Symptom-Free Days in prior 2 weeks	6.61 days STANDARD_DEVIATION 4.9 • n=5 Participants	6.88 days STANDARD_DEVIATION 4.6 • n=7 Participants	6.7 days STANDARD_DEVIATION 4.8 • n=5 Participants

PRIMARY outcome

Timeframe: At the 3-month follow-up assessment

Number of days without symptoms in the prior 2 weeks

Outcome measures

Measure	TEAM-ED Intervention Group n=165 Participants Facilitation of preventive asthma management through telemedicine assessment and follow-ups in addition to guideline-based provider prompting TEAM-ED: Facilitation of preventive asthma management through telemedicine assessment and follow-ups in addition to guideline-based provider prompting	Enhanced Usual Care n=157 Participants Report of symptoms to primary care physician Enhanced Usual Care: Report of symptoms to primary care physician
Number of Symptom-Free Days in the Prior 2 Weeks	9.5 days Standard Deviation 4.9	10.1 days Standard Deviation 4.6

PRIMARY outcome

Timeframe: At the 6-month follow-up assessment

Number of days without symptoms in the prior 2 weeks

Outcome measures

Measure	TEAM-ED Intervention Group n=161 Participants Facilitation of preventive asthma management through telemedicine assessment and follow-ups in addition to guideline-based provider prompting TEAM-ED: Facilitation of preventive asthma management through telemedicine assessment and follow-ups in addition to guideline-based provider prompting	Enhanced Usual Care n=159 Participants Report of symptoms to primary care physician Enhanced Usual Care: Report of symptoms to primary care physician
Number of Symptom-Free Days in the Prior 2 Weeks	10.2 days Standard Deviation 4.6	10.4 days Standard Deviation 4.3

PRIMARY outcome

Timeframe: At the 9-month follow-up assessment

Number of days without symptoms in the prior 2 weeks

Outcome measures

Measure	TEAM-ED Intervention Group n=155 Participants Facilitation of preventive asthma management through telemedicine assessment and follow-ups in addition to guideline-based provider prompting TEAM-ED: Facilitation of preventive asthma management through telemedicine assessment and follow-ups in addition to guideline-based provider prompting	Enhanced Usual Care n=145 Participants Report of symptoms to primary care physician Enhanced Usual Care: Report of symptoms to primary care physician
Number of Symptom-Free Days in the Prior 2 Weeks	10.4 days Standard Deviation 4.6	10.5 days Standard Deviation 4.3

PRIMARY outcome

Timeframe: At the 12-month follow-up assessment

Number of days without symptoms in the prior 2 weeks

Outcome measures

Measure	TEAM-ED Intervention Group n=146 Participants Facilitation of preventive asthma management through telemedicine assessment and follow-ups in addition to guideline-based provider prompting TEAM-ED: Facilitation of preventive asthma management through telemedicine assessment and follow-ups in addition to guideline-based provider prompting	Enhanced Usual Care n=144 Participants Report of symptoms to primary care physician Enhanced Usual Care: Report of symptoms to primary care physician
Number of Symptom-Free Days in the Prior 2 Weeks	10.3 days Standard Deviation 4.8	10.0 days Standard Deviation 4.7

Adverse Events

TEAM-ED Intervention Group

Serious events: 0 serious events

Other events: 0 other events

Deaths: 0 deaths

Enhanced Usual Care

Serious events: 0 serious events

Other events: 0 other events

Deaths: 0 deaths

Serious adverse events

Adverse event data not reported

Other adverse events

Adverse event data not reported

Additional Information

Jill Halterman

University of Rochester

Phone: 5852755798

Email: jill_halterman@urmc.rochester.edu

Results disclosure agreements

• Principal investigator is a sponsor employee
• Publication restrictions are in place